Frequently Asked Questions
Index of Common Questions
- What is your mission?
- Are you listed on GuideStar?
- Who is responsible for ensuring good governance?
- What is a Resident Institutional Lead Investor and why does it matter for Arizona?
- What are some of the types of programs that can be supported by AZAdvances?
- Who is leading the Capital Campaign?
- How are the endowments structured?
- Where are the endowments maintained?
- Is my donation tax deductible?
- Are non-cash donations accepted?
- Do you accept in-kind donations and welcome volunteer services?
- How is AZAdvances different than AZ-HCIF?
The mission of AZAdvances ™ is to provide entrepreneurial education and support, including grants and mission related investments into Arizona life science companies , that help to advance life changing and life saving products and services along the path from discovery to development to delivery.
AZAdvances is a division of the Opportunity Through Entrepreneurship Foundation (OTEF) a 501c3 non profit and grass roots organization that provides entrepreneurial education, mentoring and support to individuals and organizations.
The mission of the Opportunity Through Entrepreneurship Foundation (OTEF) is to provide a path to for economic sustainability to at-risk populations that are often forgotten or left behind and to support entrepreneurs and innovators to deliver products and services which improve the world around us.
Maintained as separate accounts within the Opportunity Through Entrepreneurship Foundation (OTEF), a 501c3 public charity established in 2005, AZAdvances is structured to make an impact today and for generations to come.
AZAdvances is designed to address our early stage life science funding challenge in a way that is both strategic and sustainable. Combining the immediate impact of a current use fund with a separate evergreen endowment, the AZAdvances structure, once capitalized, can provide a steady stream of early stage capital move Arizona-based health innovations forward.
- The AZAdvances Today Fund is a current use fund designed to accept donations and distributions from the AZAdvances Legacy fund. The AZAdvances Today Fund will distribute grants and mission related investments base on the needs of the life science ecosystem and the projects that have the greatest potential for future impact in accordance with our mission and as directed by the AZAdvances Board of Trustees..
- The AZAdvances Legacy Fund is a long-term, evergreen endowment designed to grow the core capital and make annual distributions into the AZAdvances Today Fund.
- Special Purpose Funds may be established based on donor request for express purposes that are consistent with our mission.
Banking and Investments
The Opportunity Through Entrepreneurship Foundation (OTEF) currently maintains its accounts at Wells Fargo Bank. As the AZAdvances accounts grow, the OTEF Board of Directors and the AZAdvances Trustees will determine what additional fiduciary services are required to manage the core capital, equity holdings, and distributions.
AZAdvances Trustees will evaluate applications to determine which programs and projects can deliver the greatest impact.
The equity generated from AZAdvances mission related investments is held within the AZAdvances Legacy Endowment. By reinvesting future returns from AZAdvances’ early stage investments, AZAdvances will grow the base endowment so that the distributions can grow as the endowment grows. To maintain an appropriatelt diversified investment portfolio, the core capital of the AZAdvances Legacy Endowment will be invested in a growth-oriented, diversified portfolio of public and private investments.
Through OTEF, AZAdvances will make the distributions to the approved projects out of the AZAdvances Today Fund. In the case of grants, the AZAdvances trustees will administer and track performance. In the case of early stage investments, they will become part of the holdings of the AZAdvances Legacy Endowment. As theseinvestments mature and exit, they will help to build the value of the core capital so that the AZAdvances has greater capacity to support the community in the future.
Why pursue an endowment model?
Unlike traditional fund models that raise funds, invest them and are completed, the AZAdvances Legacy Endowment is designed as a single capital campaign followed by ongoing investment for years to come. In addition, as the base endowment grows, it provides additional support for future needs and growth.
Access to capital has been key objective of Arizona’s Bioscience Roadmap since its creation in 2002 and is one of the few items that continue to be an ongoing growth challenge for Arizona’s life science sector. While Arizona has explored various solutions over the years including state funding, privately managed fund of fund structures and other solutions, none have yielded results. Arizona continues to lag its peer group in venture capital funding, and Arizona’s life science employment growth percentage continues to lag its growth in the number of firms.
Donations to AZAdvances may be designated by donors for either the AZAdvances Legacy Endowment which is structured as a traditional endowment structure with a planned 5% annual distribution; for the AZAdvances Today Fund which is designated for current use, or for specified programs as may be offered from time to time.
Why is de-risking early stage opportunities important?
Early stage investors have many options for their investment dollars. Life science opportunities, especially those that are early in the development cycle, can appear daunting at best. AZAdvances’ endowment based model allows companies to access the capital needed to move further along the development cycle and begin to mitigate early development risk.
In addition, AZAdvances grants to local incubators and accelerators can help to provide access to experienced life science personnel and other business resources that help the companies to mature faster, further mitigating investment risk. As the degree of risk declines over time, the level of investment will naturally increase.
What is the impact of having a Resident Institutional Lead Investor in Arizona?
History has shown that when Arizona had institutional investment focused on the life science sector based in the state, levels of life science venture investment were significantly higher.
AZAdvances’ investments into Arizona life science companies, at the direction of the AZAdvances trustees, can serve as a first institutional investor for local companies and provide syndication support to additional local and out of state investment partners.
AZAdvances’ endowment model also provides a steady stream of investment capital inside the state so that the peaks and valleys of traditional venture fund structures can be avoided. In addition, through AZAdvances’ support of incubators and accelerators across Arizona’s life science innovation ecosystem, entrepreneurs are better supported and more likely to succeed.
Image Source: Source: TEConomy Partners for the Flinn Foundation Arizona Bioscience Roadmap Update (2018)
What are some of the types of programs that can be supported by AZAdvances?
AZAdvances programs are divided into two areas, grants to non-profits that strengthen the life science ecosystem and mission related investments into early stage life science companies.
Grants to Nonprofits
Mission Related Investments
- Supporting Incubator & Accelerator activities
- Matching grants for feasibility studies or proof-of-concept grants to non-profit research institutes
- Hosting Investor Events
- Acquiring Shared Resources & Equipment
- Licensing Shared Information Databases
- Programs that support developing tomorrow’s talent
- SBIR Matching Investments
- Angel Investment Matching
- Direct or Co-investment
Investments may take the form of Convertible Notes for seed investments or Equity based investments as determined by the AZAdvances Trustees on a case by case basis.
How can this help keep companies here?
There is always a risk that promising young firms will be drawn away or forced to move in their quest for investment dollars. Past experience has shown that the best way to keep companies in place is to root them in the community. Companies are rooted by investments in facilities, strategic partnerships with universities or clinical partners, or by key local talent. Past examples of well rooted companies that stayed and continue to grow here include Ventana (Roche), Abraxis (Celgene), Ulthera (Merz), CBR (California Cryobank) and MicroRel (Medtronic).
How will the AZAdvances Trustees make grant or investment decisions?
All decisions on grants and investments made by AZAdvances will be directed by the AZAdvances Board of Trustees based on what they believe will have the greatest potential for impact each year. Each year the the AZAdvances Trustees will determine the mix of available grant and investment dollars that will have the greatest potential impact. It will be up to the then-current AZAdvances Trustees to establish or adjust its grant making policies or allocations in accordance with AZAdvances’ mission. AZAdvances mission is specific to Arizona. At no time will the AZAdvances Trustees approve allocations for projects that are outside of Arizona or that do not specifically impact Arizona-based operations.
AZAdvances Trustees may approve direct-expenditure grants to non-profit organizations consistent with the our mission, the needs of local ecosystem and the terms of applicable grant agreements. Grants will be paid by OTEF at the direction of the AZAdvances Trustees to the grantee.
Mission Related Investments
AZAdvances Trustees may direct AZAdvances to make investments in or lend to for-profit companies from its annual distribution that are consistent with its mission and the then-current investment criteria approved by AZAdvances Trustees and the AZAdvances Investment Committee. Investments or loans will be made by AZAdvances and managed within the AZAdvances separate account at OTEF.
Due diligence is an essential component of any investment strategy and can be even more complex in the life science sector. In addition to internal due diligence resources. AzAdvances will leverage its relationships with Arizona’s Angel Groups, Life Science Incubators and Accelerators, Universities, Private Research Institutes and Hospital systems for additional insights.
To request more information, please contact us.
Is my gift tax deductible?
The Opportunity Through Entrepreneurship Foundation was incorporated in the State of Arizona in 2005 and is organized under Arizona Law. The Opportunity Through Entrepreneurship Foundation was granted IRS Section 501c3 public charity status on November 2, 2005. EIN# 20-3779020
Please consult your tax advisor with questions about how your donation applies to your personal tax situation.
How can I help?
There are many ways that members of our community can get involved in helping AZAdvances achieve the goal of building a $200 Million Endowment within the AZAdvances Legacy Endowment and within a $50 Million AZAdvances Today Fund.
In-kind Professional Services
- Marketing and Communications Support
- Legal Services (IP and General Business)
- Business Advisory
- Market Research
- Social Media Outreach
- Community Outreach & Introductions
- Database support
- Hosting Events
For specific ideas on how you can get involved, contact us.
Can I contribute gifts of stocks or other securities?
Giving appreciated securities (publicly traded or closely held), bonds, or mutual fund shares is an option. A gift of appreciated securities may qualify for a charitable tax deduction and may avoid the long-term capital gains tax on the appreciated value of the asset. Stocks or bonds held more than one year that have increased in value may qualify for a deduction equal to the full market value of the gift. With stocks or bonds worth less than the price you paid for them, the wisest course is to sell them and give the cash proceeds. The sale will establish a loss that may offset other capital gains income.
To discuss a non-cash donation, please contact us.
Please consult your tax advisor with questions about the deductibility of these gifts and how it applies to your personal tax situation.
Who is leading the AZAdvances Capital Campaign?
A coalition of nonprofit organizations has come together to raise $200 million AZAdvances Legacy Endowment and a $50 million AZAdvances Today Fund to support the commercialization of life changing and lifesaving healthcare innovations that are developed by Arizona-based researchers and entrepreneurs.
The founding members of the coalition include the Arizona Bioindustry Association, Inc. (AZBio) and the Opportunity Through Entrepreneurship Foundation, Inc. (OTEF), a 501c3 pubic charity based in Arizona.
This is the second collaboration between OTEF and AZBio. The first was the creation of D3Bio, a division of OTEF, which launched in 2014 to support life science innovation and life science innovators along the pathway from discovery to development to delivery. D3Bio’s most popular program, the Student Discovery Zone held at AZBio Signature Events has provided over 900 Arizona high school and university students with the opportunity to share the results of student run research projects with industry leaders.
Commitment to transparency and governance
When a donor commits their resources to a non-profit organization, we believe that they should have access to information about our organization, including our current plans, the metrics we set, the outcomes we achieve, and more. That is why we include our most up to date information on GuideStar.
The Arizona Bioindustry Association (AZBio) has earned a 2019 Platinum Seal of Transparency, the highest level of recognition offered by GuideStar, the world’s largest source of nonprofit information. By sharing metrics that highlight progress AZBio is making toward its mission, the organization is helping donors move beyond simplistic ways of nonprofit evaluation such as overhead ratios. View AZBio’s GuideStar Profile.
To reach the Platinum level, AZBio added extensive information to its GuideStar Nonprofit Profile: basic contact and organizational information; in-depth financial information; qualitative information about goals, strategies, and capabilities; and quantitative information about results and progress toward its mission. By taking the time to provide this information, AZBio has demonstrated its commitment to transparency and to giving donors and funders meaningful data to evaluate nonprofit performance.
AZBio’s metrics focus on the documented results that Arizona’s Bioindustry is generating in the creation of firms and jobs along with venture investment as a measure of growth potential. It also contains our quintile ranking nationally as compared to other states. AZBio has also highlighted just some of the programs designed to increase our industry’s growth potential specifically in the areas of: improving the availability of early stage capital; increasing the awareness of the value our industry delivers; and providing opportunities for students that support our future talent pipeline.
As a grass roots organization, the Opportunity Through Entrepreneurship Foundation has leveraged the power of community volunteers to deliver educational programming since 2005. As its annual receipts were under $50,000, OTEF began submitting a 990-N information return with the IRS beginning in 2011. View OTEF’s IRS 990-N History It is expected that due to donations to AZAdvances, OTEF will be filing the long form IRS 990 information returns beginning in the 2020 tax year.
OTEF is in the process of updating its GuideStar Profile. For the current version click here to view OTEF’s GuideStar Profile.
Who are the AZAdvances Trustees?
The AZAdvances Board of Trustees will be comprised of Arizona Leaders as well as at least one Trustee serving on the OTEF board of directors as board liaison. The current AZAdvances Trustees are provided below. Additional Trustees will be nominated and approved by the OTEF Board of Directors as the endowment builds.
- Russ Yelton currently serves as Chair of the AZAdvances Trustees; President of Yelton Associates; Board Member at Pinnacle Transplant Technologies, Inc. where he previously served at CEO; Member of the Arizona Bioscience Roadmap Steering Committee; a member of the Phoenix Forward Bioscience Leadership Council; and Past-Chairman of the Board at AZBio. A leader in Arizona’s Bioscience and Business communities, Russ served as CEO of Pinnacle Transplant (2014-2017), is a past Board Member of the National Business Incubation Association; and is nationally recognized for his expertise in the business acceleration and incubation sector. Russ was awarded his BS, Management from Appalachian State University and his MBA from Western Carolina University.
- Joan Koerber-Walker , currently serves as an AZAdvanaces Trustee and as the board liaison to OTEF where she has served as chair of the board since 2006 . (See below for Joan’s expanded bio.)
Who governs the Opportunity through Entrepreneurship Foundation ?
The Directors of the Opportunity Through Entrepreneurship Foundation are:
- Joan Koerber-Walker, MBA currently serves as Chairman of the Opportunity Through Entrepreneurship Foundation (OTEF) and President & CEO, Arizona Bioindustry Association (AZBio). Joan’s career includes past roles as CEO of the Arizona Small Business Association; as Treasurer and Board Member for RiboMed Biotechnologies, Inc.; and as an executive at Avnet, Inc, where, for over a 20 year span, she held a wide variety of roles in sales, marketing, technology, supply chain management, and global administration. She has served in the non profit community for over two decades including as a member of the Board of Trustees of the National Small Business Association in Washington D.C.; Chair of the Board of Advisors to CPLC Parenting Arizona, a child abuse prevention agency that provides family support services across Arizona; and as a member of the Executive Committee of the Industry Advisory Board for the Thomas and Joan Read Center at Texas A&M University. Joan was awarded a BA in Economics from the University of Delaware, an MBA from the W.P. Carey School of Business at Arizona State University, and is a member of Beta Gamma Sigma.
- Rob Dunaway, Esq. currently serves as a Director and Secretary of the Opportunity Through Entrepreneurship Foundation (OTEF). Dunaway is one of the most experienced business attorneys in Arizona, and over the past several decades has helped thousands of companies of all sizes to succeed. From his start in the Silicon Valley, counseling technology companies like Sun Microsystems and Tandem Computers, to his 17 years in Arizona guiding hundreds of startup ventures – including over 50 merger & acquisition transactions and over 400 private investor fundings. Dunaway’s Phoenix business law practice specializes in helping companies of all types build a solid foundation and grow into a thriving business. Dunaway’s expertise is focused on general corporate, contract and intellectual property law, with an emphasis on corporate and LLC formation, technology licensing and other technology-related contracts such as consulting, OEM, distribution and development agreements; venture capital and other private investor financings; mergers and acquisitions; protection of intellectual property; and internet law.
- Ed Nusbaum currently serves as a Director of the Opportunity Through Entrepreneurship Foundation (OTEF). Nusbaum is a cofounder and partner of Stealthmode Partners. Since 2008, he has served on the board of the Monterey Institute for Technology and Education. The Monterey Institute for Technology and Education [montereyinstitute.org] is a non-profit organization committed to improving access to education. Previously, Ed has served as a board member of the Arizona Technology Council, Arizona Internet Professionals Association, AeA, and TiE-Arizona. (EdNusbaum.com)
- Francine Hardaway, PhD currently serves as Executive Director and is a non-voting member of the OTEF Board. Dr. Hardaway is the co-founder of Stealthmode Partners, an accelerator and advocate for entrepreneurs in technology and health care that was founded in 1998. Prior to Stealthmode, she owned two marketing companies, and served as Director of Worldwide Press Relations for Intel and the CMO of Innovative Environmental Products. Her communications specialties are technology, healthcare and financial services. She was an Entrepreneurial Fellow of the Eller Entrepreneurship Center at University of Arizona, and was a founder of Social Media Club Arizona and the Arizona Software Association. She is co-founder of the blog USHealthCrisis, and blogs for Fast Company, Huffington Post, and Stealthmode’s blog
AZAdvances replaces AZ-HCIF
In October of 2017, the Opportunity Through Entrepreneurship Foundation (OTEF) and the Healthcare Impact Foundation (HCIF), a 501c3 non-profit based in New York City, entered into a Memorandum of Understanding (MOU) to form Healthcare Impact Foundation-Arizona or AZ-HCIF. The goal was to build a solution to address the early-stage funding challenge that slows the progress of innovation within Arizona life science companies . AZ-HCIF would be further supported by the Arizona Bioindustry Association (AZBio). With over 200 life science companies as members and with deep ties across the community, AZBio would provide vital insights and help build the infrastructure necessary for the project to move forward.
In December of 2018, AZBio announced that it has been awarded a $299,750 grant from the U.S. Economic Development Administration’s (EDA) 2018 Regional Innovation Strategies (RIS) program competition to support the creation of a sustainable seed fund for life science innovation in Arizona. In addition to the federal contribution to the project, AZBio and its partners will provide matching support in excess of $500,000 over the three-year term of the project. These resources support the seed fund capital campaign, structure and operations as well as programs designed to help Arizona life science companies prepare for the investment process. Under the terms of the grant, neither the federal funds or the matching funds may be used to capitalize the fund itself or for direct investment into individual companies. (Press release)
With support from the EDA Grant, a Capital Campaign study was commissioned by AZBio in the spring of 2019. As part of the study, we sought input from the community on what would be needed to achieve the goals of the capital campaign and ultimately to support our mission to provide entrepreneurial education and support, including grants and mission related investments into Arizona life science companies that help to advance life changing and life saving products and services along the path from discovery to development to delivery.
Based on the input received, OTEF leadership worked with HCIF leadership to address needs identified in the study and to evaluate what would be the best way to move forward. This resulted in the termination of the MOU with HCIF.
With the full support of the OTEF Board of Directors, AZAdvances was created within OTEF to support the mission and to ensure that we are fully responsive to the needs of our community, our donors, and our supporters.
As of September 30, 2019, all funds held in escrow for AZ-HCIF by HCIF have been transferred back to OTEF for AZAdvances .
OTEF, including AZAdvances, has no remaining business relationship with HCIF. We wish HCIF success as they pursue their mission.
As more questions are received, this page will be updated.